Equity Research Report Template (Reg AC, MAR Art. 20)
Initiation report: key data, thesis, business, industry, financials, forecasts, valuation and target price, risks, ESG, Reg AC and MAR disclosures
使い方: Use it when publishing or presenting a stock recommendation with a target price, from a sell-side initiation to a student fund report. Fill the rating definitions, the price date and time and the disclosure section with compliance first. The main pitfall is a target price that cannot be recomputed from the valuation shown.
プレビュー
Equity Research Report: [Company name] ([Ticker])
An initiation-of-coverage style equity research report on one listed company: key data and recommendation, investment summary, business description, industry and competitive positioning, financial analysis, forecasts, valuation and target price, catalysts, risks, ESG considerations, the required disclosures and analyst certification, and appendices. The disclosure section maps to US Regulation AC (17 CFR 242.500 to 242.505), FINRA Rule 2241 (cited by number only), EU Market Abuse Regulation (EU) No 596/2014 Article 20 and Commission Delegated Regulation (EU) 2016/958. The worked example covers "Halvard Tools", a fictional listed toolmaker; every figure is invented. Replace every
[bracketed]value and every row marked Example. This is a document format, not financial, investment, tax, legal or accounting advice, and not a recommendation on any real security. Obtain the standard or law for the normative text.
Document control
| Field | Value |
|---|---|
| Document ID | [ER-2026-001] |
| Report type | [Initiation / Update / Flash note / Change of rating] |
| Company and listing | [Company], [Exchange], [Ticker] |
| Sector | [Sector / industry] |
| Version | [1.0] |
| Status | [Draft / Compliance review / Published / Withdrawn] |
| Owner (lead analyst) | [@lead-analyst], [Job title] |
| Other contributors | [@analyst-2], [Job title] |
| Approvers/reviewers | [@supervisory-analyst], [@compliance-reviewer] |
| Producing legal entity | [Firm legal name] |
| Competent authority | [Regulator of the producing firm] |
| Self-regulatory code (producers that are not investment firms or credit institutions) | [Code name and version, or "Not applicable"] |
| Production completed | YYYY-MM-DD HH:MM [time zone] |
| First dissemination | YYYY-MM-DD HH:MM [time zone] |
| Price reference | [Price] at [close / time], YYYY-MM-DD |
| Planned update frequency | [After each results release and at least every n months] |
| Classification | [Public / Clients only / Internal] |
| Last updated | YYYY-MM-DD |
Approvals
| Role | Name | Decision | Date |
|---|---|---|---|
| Lead analyst | [@lead-analyst] | [Submitted] | YYYY-MM-DD |
| Supervisory analyst or research head | [@supervisory-analyst] | [Approved content] | YYYY-MM-DD |
| Compliance | [@compliance-reviewer] | [Approved disclosures] | YYYY-MM-DD |
Revision history
| Version | Date | Author | Change |
|---|---|---|---|
| 0.1 | YYYY-MM-DD | [@lead-analyst] | Draft for internal review |
| 1.0 | YYYY-MM-DD | [@lead-analyst] | Published initiation |
Contents
- Key data and recommendation
- 1. Investment summary
- 2. Business description
- 3. Industry overview and competitive positioning
- 4. Financial analysis
- 5. Forecasts and key assumptions
- 6. Valuation and target price
- 7. Catalysts
- 8. Investment risks
- 9. ESG considerations
- 10. Disclosures and analyst certification
- 11. Student competition mode
- 12. Appendices
- 13. Glossary and references
- Standard and licence note
Key data and recommendation
| Item | Value (Example) |
|---|---|
| Company | Halvard Tools (fictional), [Exchange], [Ticker] |
| Recommendation | Hold (initiation) |
| 12-month target price | EUR 44.70 (horizon end 2027-12-31) |
| Reference price | EUR 42.00, close 2027-02-18 |
| Upside to target | 6.4% |
| Expected dividend (2027E) | EUR 0.95 (yield 2.3%) |
| Expected 12-month total return | 8.7% |
| Market capitalisation | EUR 5,040m |
| Enterprise value (net debt EUR 600m including leases) | EUR 5,640m |
| Diluted shares | 120.0m |
| Free float | [n%] |
| 52-week range | EUR 36.40 to EUR 49.80 |
| Average daily traded value (3 months) | [EUR n m] |
| EUR m, year to December (Example) | 2026A | 2027E | 2028E | 2029E |
|---|---|---|---|---|
| Revenue | 3,000.0 | 3,150.0 | 3,301.2 | 3,433.2 |
| EBITDA (normalised) | 450.0 | 519.8 | 561.2 | 600.8 |
| EBIT (normalised) | 345.0 | 409.5 | 445.7 | 480.7 |
| Net income | 236.3 | 286.1 | 314.7 | 342.5 |
| Diluted EPS (EUR) | 1.97 | 2.38 | 2.62 | 2.85 |
| DPS (EUR) | 0.80 | 0.95 | 1.05 | 1.14 |
| P/E at EUR 42.00 | 21.3x | 17.6x | 16.0x | 14.7x |
| EV / EBITDA at EUR 5,640m | 12.5x | 10.9x | 10.0x | 9.4x |
Rating definitions (Example; use your firm's approved definitions): Buy, expected 12-month total return above 10%; Hold, between -5% and 10%; Sell, below -5%. Total return equals price change to target plus expected dividends. The rating horizon is 12 months unless stated.
1. Investment summary
Recommendation (Example): we initiate coverage of Halvard Tools with a Hold rating and a 12-month target price of EUR 44.70, derived from a 50/50 blend of discounted cash flow and peer EV / NTM EBITDA, rolled forward 12 months (section 6). The expected total return of 8.7% is positive but below our 10% Buy threshold.
Thesis (Example):
- Margin recovery is real but largely priced. Price increases and the closure of two plants should lift the EBITDA margin from the 15.0% trough of FY2026 to 17.5% by 2029E. At 10.9x NTM EBITDA the shares trade only modestly below the peer median of 11.5x, so most of the recovery is already in the price.
- Sound balance sheet. Net debt of EUR 600m including leases (1.3x EBITDA), with the 5.25% senior notes not due until 2031, leaves room for restructuring cash costs and a progressive dividend.
- Valuation is balanced. Our DCF (EUR 39.30) sits below the share price and peer multiples (EUR 44.81) above it; the blend supports a target close to the current price.
What would change our view: evidence that margins exceed 17% in 2027E (toward our bull case of EUR 60.40) would argue for an upgrade; a delay to the plant closures, a battery cell price shock or further retail destocking (toward our bear case of EUR 29.60) would argue for a downgrade.
2. Business description
| Item | Description (Example) |
|---|---|
| Segments (FY2026 revenue) | Power tools, mostly cordless 45%, hand tools 40%, accessories 15% |
| Geography | Europe 60%, North America 30%, rest of world 10% |
| Channels | Professional trade through dealers and distributors 55%, retail (home-improvement chains and online) 45% |
| Customer concentration | Top 10 customers 32%; largest, a home-improvement chain, 8% |
| Manufacturing | Nine plants; two close by 2028 under the footprint plan |
| Key inputs | Steel, battery cells (two suppliers), electronics |
| Management | [CEO, CFO, tenure, incentive plan metrics] |
| Ownership | [Largest holders, free float, any controlling shareholder] |
| Capital allocation | Dividend payout about 40% of net income; bolt-on acquisitions |
Describe the history only where it explains the current position, for example a recent acquisition or restructuring.
3. Industry overview and competitive positioning
3.1 Market and drivers
| Driver | Evidence and source | Direction (Example) |
|---|---|---|
| Construction and renovation activity | [Index, source, date] | Flat in 2026, recovering in 2027 |
| Industrial production | [Index, source, date] | Modest growth |
| Shift to cordless platforms | [Market study, date] | Structural growth |
| Input costs (steel, battery cells) | [Price series, date] | Volatile |
| Trade policy and tariffs | [Official source, date] | Risk for North American sales |
3.2 Competitive positioning
| Factor | Halvard Tools (Example) | Main competitors (Example) | Assessment |
|---|---|---|---|
| Brand with professionals | Strong in Europe | Tamsin stronger in North America | Advantage in home market |
| Cordless platform breadth | 120 tools on one battery system | Tamsin 250 tools | Gap, closing |
| Distribution | Long-standing dealer relationships; large retail accounts | Similar | Neutral; retailer bargaining power is a watch point |
| Cost position | Two plant closures under way | Brannoch lower cost | Improving |
| Pricing power | Price increases held in 2025 and 2026 | Similar | Neutral |
Use a recognised framework (for example five forces or a value chain view) by name if it helps, but write the analysis in your own words and tie each conclusion to a forecast or valuation input.
4. Financial analysis
4.1 Return on equity decomposition
| FY2026 (Example) | Value |
|---|---|
| Net margin (236.3 / 3,000.0) | 7.9% |
| Asset turnover (3,000.0 / 3,600.0) | 0.83x |
| Equity multiplier (3,600.0 / 1,800.0) | 2.00x |
| ROE (7.875% x 0.833 x 2.00) | 13.1% |
Equity is equity attributable to owners of the parent (EUR 1,800.0m; there are no material non-controlling interests). Use year-end or average balances consistently; the example uses year-end balances.
4.2 Key ratios
| Ratio (Example) | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
| Revenue growth | [n%] | 5.9% | 4.9% |
| Normalised EBITDA margin | 16.0% | 15.5% | 15.0% |
| Normalised EBIT margin | 12.5% | 12.0% | 11.5% |
| Capital expenditure / revenue | 4.0% | 4.0% | 4.0% |
| Net working capital / revenue | 15.0% | 15.0% | 15.0% |
| Net debt including leases / EBITDA | [n x] | [n x] | 1.3x |
| EBIT / net interest | [n x] | [n x] | 11.5x |
4.3 Cash conversion
FY2026 free cash flow to the firm (Example): EBIT EUR 345.0m less tax at 25% (EUR 86.3m) plus D&A EUR 105.0m less capital expenditure EUR 120.0m less the increase in net working capital EUR 21.0m equals EUR 222.8m, which is 49.5% of EBITDA. Comment on the trend and on any timing effects such as inventory build ahead of a product launch.
Tie the historical analysis to the forecast in three explicit links. First, explain the margin path: in the example the EBITDA margin fell by one point over two years because dealer destocking cut volumes while the fixed cost of nine plants stayed, which is why the forecast recovery depends on volume and on the two closures rather than on price alone. Second, check that reinvestment matches growth: capital expenditure above depreciation and working capital at a stable share of revenue are consistent with 4% to 5% growth; a forecast that grows faster with the same reinvestment needs a reason. Third, reconcile reported and normalised figures and show the adjustments once, so the reader can see that the 15.0% FY2026 margin excludes EUR 20m of closure and litigation costs that are cash costs all the same.
5. Forecasts and key assumptions
| Assumption | 2027E | 2028E | 2029E | Basis (Example) |
|---|---|---|---|---|
| Revenue growth | 5.0% | 4.8% | 4.0% | Dealer restocking ends, cordless volume growth, price about 2% a year |
| EBITDA margin | 16.5% | 17.0% | 17.5% | Price increases, two plant closures, mix |
| D&A / revenue | 3.5% | 3.5% | 3.5% | History |
| Capital expenditure / revenue | 4.0% | 4.0% | 4.0% | Company plan |
| Net working capital / revenue | 15.0% | 15.0% | 15.0% | Three-year level |
| Net interest including lease interest (EUR m) | 28.0 | 26.0 | 24.0 | Bank loan paydown from free cash flow |
| Tax rate | 25% | 25% | 25% | Blended statutory rate |
| Dividend payout | about 40% | about 40% | about 40% | Stated policy |
| Our estimates against consensus (Example) | 2027E ours | 2027E consensus | Difference |
|---|---|---|---|
| Revenue (EUR m) | 3,150.0 | [n] | [n%] |
| EBITDA (EUR m) | 519.8 | [n] | [n%] |
| EPS (EUR) | 2.38 | [n] | [n%] |
The full model, with income statement, balance sheet and cash flow, is in appendix 12.1.
6. Valuation and target price
6.1 Methods
| Method | Value per share | Weight | Source (Example) |
|---|---|---|---|
| DCF (WACC 8.04%, terminal growth 2.0%) | EUR 39.30 | 50% | Valuation Report [VAL-2026-001], section 8 |
| Peer EV / NTM EBITDA (median 11.5x) | EUR 44.81 | 50% | Comparable Companies Analysis [CCA-2026-001] |
| Blended fair value at 2026-12-31 | EUR 42.06 | 100% | 0.5 x 39.30 + 0.5 x 44.81 |
Cost of equity (Example):
6.2 From fair value to target price
Worked example (Example): 42.06 x 1.085 - 0.95 = EUR 44.68, rounded to EUR 44.70. We confirmed that peer multiples and the risk-free rate did not change materially between the valuation date (2026-12-31) and the reference price date (2027-02-18).
The roll-forward runs from the valuation date, so the target is a value at 2027-12-31, about 10.5 months after first dissemination on 2027-02-19. State that horizon end date with the target. Where the dissemination date is more than one month after the valuation date and your policy measures the 12 months from dissemination, roll forward over the longer period instead: 42.06 x 1.085^(14/12) - 0.95 = EUR 45.31 (Example). Pick one convention in the research policy and apply it to every report, because mixing them makes target prices across the coverage list incomparable.
6.3 Sensitivity and scenarios
| DCF value per share, EUR: WACC \ g (Example) | 1.5% | 2.0% | 2.5% |
|---|---|---|---|
| 7.54% | 40.32 | 43.37 | 47.02 |
| 8.04% | 36.78 | 39.30 | 42.26 |
| 8.54% | 33.74 | 35.85 | 38.30 |
| Scenario (Example) | Key assumptions | 12-month value | Probability |
|---|---|---|---|
| Bull | Section 5 revenue, margin 18.0% in 2028E (EBITDA EUR 594.2m), 13x NTM EBITDA at the end of 2027, net debt EUR 480.1m | EUR 60.40 | 25% |
| Base | Section 5 forecast, blended fair value rolled forward (section 6.2) | EUR 44.70 | 50% |
| Bear | 2028E revenue 5% below FY2026 (EUR 2,850m), margin 13.0% (EBITDA EUR 370.5m), 11x NTM EBITDA, net debt EUR 520m | EUR 29.60 | 25% |
| Probability-weighted | EUR 44.85 | 100% |
Scenario values (Example): bull (594.2 x 13 - 480.1) / 120 = EUR 60.37, rounded to EUR 60.40; bear (370.5 x 11 - 520.0) / 120 = EUR 29.63, rounded to EUR 29.60. Net debt of EUR 480.1m at the end of 2027E comes from appendix 12.1; the bear case adds EUR 40m for lower cash flow and restructuring costs without savings. Probability-weighted value: 0.25 x 60.40 + 0.50 x 44.70 + 0.25 x 29.60 = EUR 44.85. State whether the rating follows the base case or the weighted value; here it follows the base case target (total return 8.7%), and the weighted value ((44.85 + 0.95) / 42.00 - 1 = 9.0%) also falls in the Hold band. Build the bull and bear cases from explicit drivers, as here, and never as the base case with a different multiple only. A colleague's Stock Pitch (finance/stock-pitch) on the same company may reach a different call, for example a base value of EUR 52 at 12x FY2028E EBITDA and an expected dividend of EUR 1.10 against our DPS 2027E of EUR 0.95; record such differences and their causes (multiple, margin path, dividend assumption, horizon) rather than hiding them.
7. Catalysts
| ID | Event | Expected date | What we expect (Example) |
|---|---|---|---|
| CAT-001 (Example) | Q1 2027 trading update | 2027-04-22 | Order intake stable, price increases holding |
| CAT-002 (Example) | First plant closure complete | Q3 2027 | Confirmation of savings on plan |
| CAT-003 (Example) | Capital markets day with footprint plan | 2027-09 | Medium-term margin target of 17% to 18% |
| CAT-004 (Example) | Contract renewal with the largest retail customer | 2027-11 | Renewal on similar terms |
A catalyst is useful only if the report says what outcome would confirm or contradict the thesis and how the value would move. For each event, record before publication the result you expect and the result that would make you revisit the rating, so the next update can be judged against a stated test rather than rewritten after the fact.
8. Investment risks
| ID | Risk | Probability | Impact | Effect on value | Mitigant or monitor (Example) |
|---|---|---|---|---|---|
| RSK-001 (Example) | Plant closures delayed | Medium | Medium | About EUR 2 per share | Monthly project updates |
| RSK-002 (Example) | Battery cell cost spike | Medium | High | Bear case | Two suppliers, price clauses |
| RSK-003 (Example) | Construction downturn in Europe | Medium | High | Bear case | Order intake, distributor stock |
| RSK-004 (Example) | Tariffs on imports into North America (30% of revenue) | Low | Medium | About EUR 1.50 per share | Policy announcements |
| RSK-005 (Example) | Retailer bargaining power and dealer consolidation | Low | Medium | Margin pressure | Contract terms, concentration |
Quantify the effect on value wherever you can, as in the table, and link each risk to the scenario that captures it. Review points for the supervisory analyst: every risk that the bear case relies on appears here; the probability words match the firm's scale; no risk is listed that the forecast already assumes away; and the monitor column names a signal that the team will actually see before the market does. A common error is a long generic list that buries the two risks that drive the rating.
9. ESG considerations
| Factor | Evidence (Example) | Materiality | Where it enters the valuation |
|---|---|---|---|
| Product energy efficiency and battery recycling | [Company disclosures, date] | Medium | Cordless demand assumption |
| Supply chain labour standards at contract manufacturers | [Audit results, date] | Medium | Risk RSK-005 and reputation |
| Plant emissions and energy costs | [Sustainability report, date] | Low | Margin assumption |
| Board independence and incentive design | [Annual report, date] | Medium | No premium applied; monitored |
State the sustainability reporting regime that applies to the company and the date of the latest data.
10. Disclosures and analyst certification
10.1 Analyst certification (United States)
Regulation AC (17 CFR 242.501) requires a broker-dealer that provides a research report to a US person in the United States to include a clear and prominent certification by the research analyst. Write it in your firm's approved wording, covering:
| Element | Entry |
|---|---|
| Views expressed accurately reflect the analyst's personal views about the subject securities and issuer | [Approved certification wording] |
| No part of compensation was, is or will be related to the specific recommendations or views, or else the source, amount and purpose of such compensation and a statement that it could influence the views | [Approved wording] |
| Public appearances certification record, made within 30 days after each calendar quarter (17 CFR 242.502) | [Compliance record reference] |
FINRA Rule 2241 (Research Analysts and Research Reports) applies to FINRA member firms that publish equity research and requires additional disclosures; FINRA Rule 2242 covers debt research. Both are cited by number only; follow your firm's procedures for the required items.
10.2 EU Market Abuse Regulation
MAR Article 20(1) requires persons who produce or disseminate investment recommendations to take reasonable care that the information is objectively presented and to disclose interests or conflicts. Delegated Regulation (EU) 2016/958 sets the technical arrangements. Checklist:
| Ref | Requirement (summary) | Where in this report |
|---|---|---|
| 2016/958 Art. 2(1) | Identity of the producer: names and job titles of the people involved and the legal person they act for | Document control |
| Art. 2(2) | Competent authority of an investment firm or credit institution producer | Document control |
| Art. 2(3) | Producer that is not an investment firm or credit institution: reference to any self-regulatory standards or code of conduct it follows | Document control |
| Art. 3(1)(a) to (c) | Facts distinguished from opinions and estimates; material sources indicated; reliability of sources | Sections 2 to 5, references |
| Art. 3(1)(d) | Projections, forecasts and price targets labelled, with material assumptions | Sections 5 and 6 |
| Art. 3(1)(e) | Date and time when production was completed | Document control |
| Art. 4(1)(a) | Statement if the report was shown to the issuer and then amended | 10.3 |
| Art. 4(1)(b) to (d) | Summary of valuation basis, methodology and assumptions, any changes, and where detailed information or proprietary model information can be found | Section 6, appendix 12.2 |
| Art. 4(1)(e) | Meaning of the rating, investment horizon and risk warning including a sensitivity analysis of assumptions | Key data, sections 6.3 and 8 |
| Art. 4(1)(f) and (g) | Planned update frequency; date and time of each price quoted | Document control, key data |
| Art. 4(1)(h) and (i) | Changes from previous recommendations in the past 12 months; list of all recommendations on any instrument or issuer in the past 12 months with required details | 10.4 |
| Art. 5 | Relationships and circumstances that may impair objectivity, including group interests | 10.3 |
| Art. 6(1) | Specific interests: net long or short position above 0.5% of issued share capital; issuer holdings above 5% of the producer; market making; lead or co-lead manager of an offer in the past 12 months; service agreements; agreement on producing the recommendation | 10.3 |
| Art. 6(2) | Organisational arrangements and information barriers; remuneration tied to investment services or trading fees; pre-offering share acquisitions by staff | 10.3 |
| Art. 6(3) | Quarterly publication of the proportion of buy, hold and sell recommendations and of issuers given material investment services | 10.4 |
| Art. 7 | Date and time of first dissemination | Document control |
Research payments in the EU: Directive (EU) 2024/2811 (part of the Listing Act package) amended the MiFID II rules on paying for research (Article 24(9a) of Directive 2014/65/EU), with transposition due in June 2026; check the national transposing law. In the UK, the onshored MAR and the FCA Handbook (COBS 12) apply; they are cited by reference only.
10.3 Interests and conflicts
| Item | Disclosure (Example) |
|---|---|
| Net position of the firm or group above 0.5% of issued share capital | [None / Long / Short] |
| Issuer holds more than 5% of the firm | [No] |
| Market maker or liquidity provider | [No] |
| Lead or co-lead manager of an offer in the past 12 months | [No] |
| Investment banking or other service agreements in the past 12 months | [No] |
| Report shown to the issuer before publication | [Factual sections only, to check accuracy; no change to rating or target price] |
| Analyst holdings in the issuer | [None] |
| Analyst remuneration linked to specific transactions | [No] |
| Information barriers | [Summary of research independence arrangements, or link] |
| Use of AI tools in research and drafting | [Tools, purpose, human review; no non-public information entered] |
10.4 Recommendation history and distribution
| Date and time | Analyst | Rating | Target price | Price at dissemination | Target validity (Example) |
|---|---|---|---|---|---|
| 2027-02-19 07:00 CET | [@lead-analyst] | Hold (initiation) | EUR 44.70 | EUR 42.00 | 12 months |
| Rating distribution, previous 12 months (Example) | Share of all recommendations | Share of issuers given material investment services |
|---|---|---|
| Buy | [n%] | [n%] |
| Hold | [n%] | [n%] |
| Sell | [n%] | [n%] |
10.5 General disclaimer
Write your firm's approved disclaimer: the nature of the report, that it is not personal advice, the risk of loss, past performance not being a guide, currency risk where relevant, distribution restrictions by jurisdiction and recipient type, and copyright.
11. Student competition mode
| ID | Check | Status |
|---|---|---|
| SC-001 | Page limits for the written report and appendices met; recent rules have allowed 10 pages plus up to 10 pages of appendices, check the current rules | [Yes / No] |
| SC-002 | Section headings and order match the official rules of the current year | [Yes / No] |
| SC-003 | Only public information used; company meetings documented | [Yes / No] |
| SC-004 | Every figure and chart has a source; consistent citation style | [Yes / No] |
| SC-005 | Model and report numbers agree; rounding consistent | [Yes / No] |
| SC-006 | AI tool use declared as the rules require | [Yes / No] |
| SC-007 | Faculty adviser and industry mentor roles within the rules | [Yes / No] |
| SC-008 | Professional-standards references (for example to the ethics standards known to CFA® Program candidates) cited by name only | [Yes / No] |
12. Appendices
12.1 Financial model summary
| EUR m (Example) | 2026A | 2027E | 2028E | 2029E |
|---|---|---|---|---|
| Revenue | 3,000.0 | 3,150.0 | 3,301.2 | 3,433.2 |
| EBITDA | 450.0 | 519.8 | 561.2 | 600.8 |
| D&A | (105.0) | (110.3) | (115.5) | (120.2) |
| EBIT | 345.0 | 409.5 | 445.7 | 480.7 |
| Net interest | (30.0) | (28.0) | (26.0) | (24.0) |
| Profit before tax | 315.0 | 381.5 | 419.7 | 456.7 |
| Tax at 25% | (78.8) | (95.4) | (104.9) | (114.2) |
| Net income | 236.3 | 286.1 | 314.7 | 342.5 |
| Capital expenditure | (120.0) | (126.0) | (132.0) | (137.3) |
| Increase in net working capital | (21.0) | (22.5) | (22.7) | (19.8) |
| Free cash flow to equity (net income + D&A - capital expenditure - increase in NWC) | 247.9 | 275.6 | 305.5 | |
| Dividends paid (prior-year DPS x 120.0m shares) | (96.0) | (114.0) | (126.0) | |
| Restructuring cash costs (excluded from normalised EBITDA) | (32.0) | (20.0) | 0.0 | |
| Net debt including leases at year end | 600.0 | 480.1 | 338.6 | 159.0 |
Net debt (Example): 600.0 - 247.9 + 96.0 + 32.0 = 480.1 at the end of 2027E. Capital expenditure includes right-of-use asset additions, so lease liabilities stay at about EUR 150m. The bank loans of EUR 100m are repaid from cash in 2028E, which is why net interest falls. The model computes each line before rounding, so a total may differ from the sum of its rounded parts by 0.1.
12.2 Valuation inputs
| Input | Value (Example) | Source |
|---|---|---|
| Risk-free rate | 3.0% | [Government bond, date] |
| Beta | 1.10 | Peer median, relevered |
| Equity risk premium | 5.0% | [Source, date] |
| Pre-tax cost of debt | 5.25% | Yield on the 5.25% senior notes due 2031 |
| Target debt weight | 10% | Market weight and peer median |
| WACC | 8.04% | 0.90 x 8.5% + 0.10 x 3.94% |
| Terminal growth | 2.0% | Long-term nominal growth view |
| EV to equity adjustments | EUR 600.0m | Net debt including EUR 150.0m of lease liabilities |
12.3 Peer multiples
| Peer (fictional) | EV / NTM EBITDA | P / NTM EPS |
|---|---|---|
| Brannoch Instruments | 10.4x | 16.9x |
| Corlett Hardware | 10.9x | 18.0x |
| Tamsin Power Tools | 11.5x | 17.6x |
| Velmar Industrial | 12.2x | 18.8x |
| Ostrand Fastening | 15.6x | 26.3x |
| Median | 11.5x | 18.0x |
13. Glossary and references
13.1 Glossary
| Term | Meaning |
|---|---|
| Initiation | First report on a company by the analyst or firm |
| Target price | Analyst estimate of the share price at the end of the rating horizon |
| Total return | Price change plus dividends over the horizon, as a percentage of the current price |
| DCF | Discounted cash flow valuation |
| NTM | Next twelve months |
| ROE | Return on equity: net income divided by equity attributable to owners |
| Consensus | Average or median of published analyst forecasts from a named provider |
| Investment recommendation | Under MAR, information recommending or suggesting an investment strategy for one or more financial instruments or issuers, intended for distribution or the public |
13.2 References
| Reference | Version or date | Use |
|---|---|---|
| Regulation AC, 17 CFR 242.500 to 242.505 (eCFR) | Current text checked 2026-10-25 | Analyst certification |
| FINRA Rule 2241 and Rule 2242 | Numbers and titles only | US research conflicts and disclosures |
| Regulation (EU) No 596/2014 (MAR), Article 20 | As amended; check the consolidated text | Objective presentation and conflicts |
| Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 | OJ L 160, 17.6.2016 | Technical arrangements for recommendations |
| Directive (EU) 2024/2811 | Transposition due June 2026 | Research payment rules under MiFID II |
Valuation Report (finance/valuation-report) | [VAL-2026-001] | Full valuation |
Comparable Companies Analysis (finance/comparable-companies-analysis) | [CCA-2026-001] | Peer multiples |
Standard and licence note
Based on US Regulation AC (17 CFR 242.500 to 242.505, a US public domain text), Regulation (EU) No 596/2014 Article 20, Commission Delegated Regulation (EU) 2016/958 and Directive (EU) 2024/2811 as published on EUR-Lex, reused with acknowledgement. Requirements are summarised in original wording and cited by article; no legal text is reproduced. FINRA rules and the UK FCA Handbook are cited by number only. Student competition and professional ethics references are names only and imply no affiliation with or endorsement by any organisation. Halvard Tools, its peers and all figures are fictional; nothing here is a view on any real security. Check the consolidated texts, your regulator's rules and your firm's procedures before use. This is a document format, not financial, investment, tax, legal or accounting advice. Template licence: MIT.
関連テンプレート
Audit Committee Report Template (UK Code, Form 20-F Item 16)
Audit committee report and quarterly pack: members, judgements, auditor tenure, independence, fee cap, pre-approval, Art. 11 report, Form 20-F Item 16
財務・投資・会計ICAAP Report Template (Pillar 2, CRD Art. 73, ECB Guide)
Bank ICAAP report: capital adequacy statement, risk inventory, normative and economic perspectives, capital plan, adverse and reverse stress, buffers, actions
財務・投資・会計ILAAP Report Template (CRD Art. 86, LCR, NSFR, Survival Horizon)
Bank ILAAP report: liquidity adequacy statement, appetite, funding plan, risk drivers, LCR and NSFR worked example, stress tests, survival horizon, CBC, FTP